Skip to main content
Amicus Therapeutics, Inc. (LON:0HF9)
London flag London · Delayed Price · Currency is GBP · Price in USD
6.57
-0.20 (-3.01%)
At close: May 2, 2025

Amicus Therapeutics Revenue

In the year 2024, Amicus Therapeutics had annual revenue of $528.30M USD with 32.29% growth. Amicus Therapeutics had revenue of $149.71M in the quarter ending December 31, 2024, with 30.09% growth.

Revenue
$528.30M
Revenue Growth
+32.29%
P/S Ratio
3.68
Revenue / Employee
$1.06M
Employees
499
Market Cap
1.54B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024528.30M128.94M32.29%
Dec 31, 2023399.36M70.12M21.30%
Dec 31, 2022329.23M23.72M7.76%
Dec 31, 2021305.51M44.63M17.11%
Dec 31, 2020260.89M78.65M43.16%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.38B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Genus 671.60M
Revenue Rankings

Amicus Therapeutics News

More News